Heron Announces Positive Topline Results from Phase 3b Clinical
HRTX: Heron Therapeutics, Inc.
2019-10-02 07:45:00
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
2019-10-02 07:45:00
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty